Bionano to Report Q4 and 2025 Results on March 23

Genomics firm to host conference call and webcast on quarterly and annual financial performance.

Published on Mar. 9, 2026

Got story updates? Submit your updates here. ›

Bionano Genomics, Inc. (Nasdaq: BNGO) announced that it will host a conference call and live webcast on Monday, March 23, 2026, at 4:30 p.m. Eastern Time to report financial results for the fourth quarter and full year 2025 and to highlight recent corporate progress.

Why it matters

As a publicly traded genomics company, Bionano's quarterly and annual financial results are closely watched by investors to gauge the firm's performance and growth trajectory in the competitive life sciences sector.

The details

Bionano will provide an update on its Q4 2025 and full-year 2025 financial results, as well as discuss recent corporate developments. A live webcast of the call will be available on the company's Investor Relations website, and a replay will be archived for at least 30 days.

  • Bionano will host the conference call and webcast on Monday, March 23, 2026 at 4:30 p.m. Eastern Time.

The players

Bionano Genomics, Inc.

A Nasdaq-listed genomics technology company that develops and markets instruments for genome analysis.

Erik Holmlin

CEO of Bionano Genomics, Inc.

Webb Campbell

Investor Relations representative at the Gilmartin Group, which provides IR services for Bionano.

Got photos? Submit your photos here. ›

What’s next

Investors and analysts will be able to access a replay of the conference call and webcast on Bionano's investor relations website for at least 30 days following the event.

The takeaway

Bionano's upcoming financial report will provide insight into the company's performance and growth in the genomics market, which is a key area of focus for many life sciences investors.